Trials / Not Yet Recruiting
Not Yet RecruitingNCT07116239
Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome
Steady-state Pharmacokinetics and Pharmacodynamics of Edoxaban in Adults With Nephrotic Syndrome: A Non-randomized Open-label, Parallel Arm and Single-center Study
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Peking University People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
A study to evaluate the impact of nephrotic syndrome on the steady state pharmacokinetics and pharmacodynamics of edoxaban compared to health volunteers, and whether edoxaban can provide an equivalent anticoagulant effect to enoxaparin sodium.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Edoxaban 60 mg | film-coated tablet, manufactured by Daiichi Sankyo Europe GmbH |
| DRUG | Enoxaparin 40 mg | enoxaparin sodium, prefilled syringe of 0.4mL injectable solution, manufactured by SANOFI WINTHROP INDUSTRIE |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-02-01
- Completion
- 2026-02-01
- First posted
- 2025-08-11
- Last updated
- 2025-08-11
Source: ClinicalTrials.gov record NCT07116239. Inclusion in this directory is not an endorsement.